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ES cell transcription networks <p>OCT4 and NANOG genomic targets were identified in mouse embryonic stem cells by ChIP-chip and were compared with previously  reported ChIP-PET results.</p>
Abstract
Background:  Genome-wide approaches have begun to reveal the transcriptional networks
responsible for pluripotency in embryonic stem (ES) cells. Chromatin Immunoprecipitation (ChIP)
followed either by hybridization to a microarray platform (ChIP-chip) or by DNA sequencing
(ChIP-PET), has identified binding targets of the ES cell transcription factors OCT4 and NANOG
in humans and mice, respectively. These studies have provided an outline of the transcriptional
framework involved in maintaining pluripotency. Recent evidence with comparing multiple
technologies suggests that expanding these datasets using different platforms would be a useful
resource for examining the mechanisms underlying pluripotency regulation.
Results: We have now identified OCT4 and NANOG genomic targets in mouse ES cells by ChIP-
chip and provided the means to compare these data with previously reported ChIP-PET results in
mouse ES cells. We have mapped the sequences of OCT4 and NANOG binding events from each
dataset to genomic coordinates, providing a valuable resource to facilitate a better understanding
of the ES cell regulatory circuitry. Interestingly, although considerable differences are observed in
OCT4 and NANOG occupancy as identified by each method, a substantial number of targets in
both datasets are enriched for genes that have known roles in cell-fate specification and that are
differentially expressed upon Oct4 or Nanog knockdown.
Conclusion: This study suggests that each dataset is a partial representation of the overall ES cell
regulatory circuitry, and through integrating binding data obtained by ChIP-chip and ChIP-PET, the
methods presented here provide a useful means for integrating datasets obtained by different
techniques in the future.
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Background
Embryonic stem (ES) cells are derived from the inner cell
mass of the embryo and possess the property of pluripotency,
which is the ability to develop into any cell lineage of the
organism [1-3]. The derivation of these cells has had signifi-
cant impact on biomedical research and has important impli-
cations for regenerative medicine. Consequently, a detailed
knowledge of the mechanisms governing pluripotency in ES
cells is necessary to realize the potential of these cells. The
homeodomain transcription factors OCT4 and NANOG are
uniquely expressed in pluripotent cell types and have essen-
tial roles during development [4,5]. For instance, Oct4 knock-
out embryos and ES cells differentiate into trophectoderm,
whereas over-expression of the gene leads to differentiation
into primitive endoderm and mesoderm lineages [6,7]. Loss
of Nanog in the early embryo and ES cells results in differen-
tiation into primitive endoderm [8,9]. Conversely, NANOG
over-expression obviates the need for the cytokine, leukemia
inhibitory factor for ES cell self-renewal [8,9]. Collectively,
these studies suggest that OCT4 and NANOG function in con-
cert to regulate pluripotency in the early embryo, and simi-
larly in ES cells to govern the transcriptional regulatory
circuitry.
Recent genomic studies in ES cells have provided the founda-
tion for understanding the genetic network that is the collec-
tive output of these pluripotency factors. Studies in both
human and mouse ES cells have used chromatin immunopre-
cipitation (ChIP) combined with genome-wide technologies
to uncover OCT4 and NANOG genomic binding events that
may underlie transcriptional regulatory circuitries involved
in maintaining a stem cell state [10-12]. Such investigations
have shown that in both species, OCT4 and NANOG occupy a
large number of transcriptionally active and silent genes,
many of which are transcriptional regulators that have been
implicated in lineage specification and cell fate determina-
tion. Moreover, a substantial overlap between the OCT4 and
NANOG genomic targets exists within each dataset, suggest-
ing that these two factors act in concert to regulate a common
set of downstream pathways. This has been further substanti-
ated by gene-expression studies following short hairpin RNA-
mediated knockdown of Oct4 and Nanog [13].
ChIP coupled with a genome-wide DNA detection platform
has been useful in studying protein-DNA interactions. The
data obtained from these different platforms, however, are
expected to exhibit variations due to the technical differences
in the methods, as well as in data analysis. To date, ES cell
binding data have been collected using ChIP-PET (paired-end
ditags) [12] and ChIP-chip [11] for mouse ES cells and ChIP-
chip for human ES cells [10]. However, comprehensive tech-
nological comparisons between ChIP-chip and ChIP-PET
indicate that composite datasets that incorporate information
from multiple platforms in a complementary fashion will be
most useful in examining these networks in a comprehensive
manner [14]. Such analysis is necessary since the binding
data obtained from different platforms can vary due to the
differences in sample processing for each method. In the
study by Kim et al. [11], the authors provide a comparison
between OCT4 and NANOG targets obtained from ChIP-chip
and previously reported ChIP-PET data [12]. However, such
overlap can vary dramatically depending on the thresholds
used for determining bound regions by each experimental
method. Since these thresholds are, to a large extent, arbi-
trary, it is important to examine how the binding data
obtained by different platforms change under a wide range of
threshold values.
To this end, we have employed ChIP-chip to identify the
genomic binding targets of the pluripotency factors OCT4 and
N A N O G  i n  m o u s e  E S  c e l l s .  A d d i t i o n a l l y ,  w e  h a v e  d e v i s e d
methods to examine these results along with previously pub-
lished data for these factors using ChIP-PET under a wide
range of binding thresholds [12]. All data have been re-
mapped to the same version of the mouse genome, and pro-
v ide  a r es ou rce  fo r s tu dyin g t h is e xpa nde d tr a nscr ipt ion al
network obtained by integrating our ChIP-chip data and pre-
viously reported ChIP-PET results. Our analyses revealed
substantially different sets of OCT4 and NANOG targets iden-
tified by each technique. However, a significant proportion of
these targets included genes encoding transcription factors
and other regulators of development in both datasets. Inter-
estingly, many of the genes identified in both studies were dif-
ferentially expressed upon Oct4 or Nanog knockdown in ES
cells, suggesting that these targets were regulated by OCT4
and NANOG. Importantly, an examination of multiple data
sources provided in this study has revealed a more compre-
hensive framework for understanding the mouse ES cell reg-
ulatory network.
Results
OCT4 and NANOG ChIP-chip binding data
DNA sequences occupied by OCT4 and NANOG in mouse ES
cells were identified in three independent biological repli-
cates using ChIP as previously described [Arrayexpress: E-
TABM-410] [10]. Samples were hybridized to microarrays
that contained oligonucleotide probes that span the region -4
to +4 kb relative to the transcriptional start sites for 19,993
annotated mouse genes and 258 microRNAs [Arrayexpress:
A-MEXP-957, Arrayexpress: A-MEXP-958]. Based on previ-
ously established criteria, bound regions were identified as
peaks of ChIP-enriched DNA that span closely neighboring
probes (Figure 1a-d) (Additional data files 1, 2, 15 and 16)
[10]. Moreover, only those regions that were bound in all
three replicates are represented in the final dataset. Using
these stringent parameters, we identified 1,351 (6.8%) and
1,124 (5.6%) known protein-coding genes (Additional data
file 5) and 22 (8.5%) and 23 (8.9%) microRNA genes (Addi-
tional data file 6) that are occupied by OCT4 and NANOG,
respectively.http://genomebiology.com/2008/9/8/R126 Genome Biology 2008,     Volume 9, Issue 8, Article R126       Mathur et al. R126.3
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Illustrative examples of ChIP-enrichment ratios of (a, b, e) OCT4 and (c, d, f) NANOG bound regions obtained from ChIP-chip experiments with  promoter arrays (a-d) and chromosome 19 arrays (e, f) Figure 1
Illustrative examples of ChIP-enrichment ratios of (a, b, e) OCT4 and (c, d, f) NANOG bound regions obtained from ChIP-chip experiments with 
promoter arrays (a-d) and chromosome 19 arrays (e, f). The chromosomal position of the genes, as well as the genomic scale, is represented along the x-
axis. The fold enrichment of the probes is shown on the y-axis. These enrichment ratios represent the medians of the per-pixel ratios scanned at each spot 
on the microarray. Exons and introns are represented by boxes and horizontal lines, respectively. The transcription start site and direction of 
transcription are denoted by arrows. (g) Venn diagram depicting the overlap between gene whose promoters were bound by both OCT4 and NANOG 
in ChIP-chip experiments (p-value < 0.001).
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Several lines of evidence indicated that this ChIP-chip dataset
is of high quality (see Additional data files 13 and 15 for error
rate estimation by gene-specific PCR). First, in accordance
with previous findings in both mouse and human ES cells
[10,12], Gene Ontology (GO) analyses revealed that a signifi-
cant number of promoters occupied by OCT4 and NANOG
contained transcription factors and genes involved in devel-
opmental processes (Additional data file 7). Some of these
genes, such as Jarid2, Cdx2 and Sox2 have been identified
previously as OCT4 or NANOG targets [12]. Additionally, as
seen in both the human and mouse ES cell studies, OCT4 and
NANOG bind to their own as well as each other's promoters
[10,12,15,16]. We also observed a substantial overlap between
the OCT4 and NANOG-bound genes, where 373 gene promot-
ers were occupied by both these factors (Figure 1g). Together,
these binding data support prior models suggesting that
OCT4 and NANOG act together to maintain ES cell pluripo-
tency by promoting self-renewal and by regulating a number
of developmentally important genes.
Given that it has been reported that a significant number of
binding sites may be located outside of promoter regions [12],
we next hybridized the OCT4 and NANOG ChIP samples to
chromosome arrays that tiled the entire non-repeat portion of
mouse chromosome 19 [Arrayexpress: A-MEXP-956]. Bind-
ing events were analyzed similarly to the promoter arrays and
occupied regions were identified using the same criteria
(Additional data files 8, 15 and 17). In addition to promoter
regions bound by OCT4 and NANOG, this analysis revealed
OCT4 and NANOG binding sites that were undetectable on
the promoter arrays (Figure 1e,f). Bound regions were classi-
fied in relation to the nearest gene within 100 kb as: 5' proxi-
mal (0-10 kb upstream), 5' distal (10-100 kb upstream), 3'
proximal (0-10 kb downstream), 3' distal (10-100 kb down-
stream) and intragenic (within the gene). Sites that were
located >100 kb away from the nearest gene were classified as
gene desert regions. We identified 208 binding events for
OCT4 and 381 for NANOG using the chromosome array. For
both factors we observed similar trends in distribution of
these binding sites across chromosome 19 (Figure 2). Among
OCT4 targets, 38.9% of the sites were in intragenic, 7.7% in
the 3' proximal, 17.8% in the 3' distal, 7.2% in 5' proximal,
12.5% in 5' distal, and 15.9% in gene desert regions. Following
a similar distribution, the NANOG data showed 40.9% of the
binding sites in intragenic, 7.3% in the 3' proximal, 15.2% in
the 3' distal, 7.1% in 5' proximal, 14.2% in 5' distal, and 15.2%
in gene desert regions. These results show that OCT4 and
NANOG targets are located across different genomic regions,
and such extensively tiled arrays can be used to obtain more
detailed binding data on a genome-wide scale. Additionally,
the finding that approximately 40% of the binding sites were
found in intragenic regions is also in concordance with earlier
observations made in the ChIP-PET study for both OCT4 and
NANOG, indicating that the chromosome 19 array results are
representative of the binding distribution in the genome.
OCT4 and NANOG ChIP-PET data
In order to compare genomic targets across different plat-
forms, we re-analyzed previously reported ChIP-PET experi-
mental data for OCT4 and NANOG [12]. In the ChIP-PET
method, immuno-enriched DNA fragments are cloned into a
plasmid library, which is then transformed into one contain-
ing concatenated signature paired-end ditag sequences. The
DNA fragments or binding sites are subsequently sequenced
and the reads are mapped to the mouse genome. All binding
sites were first classified relative to the nearest gene (as intra-
genic, 5'distal, 5' proximal, 3' distal, 3' proximal and gene
desert regions), according to the criteria described earlier.
Next, we performed GO analyses on the ChIP-PET targets in
each of these regions. We observed that similar to ChIP-chip
data, both OCT4 and NANOG binding targets had a signifi-
cant representation of genes encoding transcription factors
and regulators of cell fate (Additional data file 7).
In order to analyze the ChIP-PET and ChIP-chip data
together, all raw ChIP-PET sequence reads were re-mapped
to the same version of the mouse genome (mm6) used in the
ChIP-chip experiments. The sequence reads were between 34
and 36 bp, and only those that had at least 34 matched base
pairs and a gap-length of 10 bp were considered to be
uniquely mapped to the mouse mm6 genome. Out of 951,437
OCT4 reads, 198,802 (20.9%) could be uniquely mapped.
Similarly, among 624,237 NANOG reads, 333,248 reads
(53.4%) could be mapped uniquely to the genome. Impor-
tantly, the methods and criteria used to remap data to a dif-
ferent genome version will provide a useful resource for
performing such analyses with other sequencing based plat-
forms that use other genome versions.
In ChIP-PET experiments, a minimum number of overlap-
ping sequence reads was used as a criterion for identifying
binding events. A region was considered occupied by OCT4
and NANOG if it had at least four or three overlapping
sequence reads, respectively. In order to analyze our ChIP-
chip findings in relation to these data, we examined only
those ChIP-PET reads that had corresponding regions repre-
sented on the mouse promoter arrays (576 for OCT4 and 924
for NANOG). Additionally, for chromosome 19, 90 OCT4 tar-
gets and 224 NANOG targets could be remapped for the
ChIP-PET data.
Examination of ChIP-chip and ChIP-PET bound 
regions
To examine the binding events obtained by ChIP-chip and
ChIP-PET, we used the 'Genomic Spatial Events' (GSE) Visu-
alizer program [17] (Figure 3) (Additional data file 15). GSE is
a Java software package, written to allow interactive browsing
of ChIP-chip and ChIP-PET data, and genome annotations,
from a remote database over a network connection (software
for this program is available upon request). It handles data-
sets that are simultaneously mapped against multiple
genome builds, a requirement for any system that is tohttp://genomebiology.com/2008/9/8/R126 Genome Biology 2008,     Volume 9, Issue 8, Article R126       Mathur et al. R126.5
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compare new experimental data against older datasets. The
software is built to run on multiple platforms, and also pro-
vides a software interface for custom-written analysis mod-
ules. The locations of bound probes from replicate ChIP-chip
experiments, as well as the overlapping ChIP-PET reads for
the respective regions, could be simultaneously visualized
using the program. Therefore, this tool provides an important
resource to compare data from multiple sources at a variety of
genomic scales. It can also be utilized in the future for such
purposes as data using other technologies become available
for expanding the ES cell transcriptional circuitry.
In order to determine how the analysis methods and thresh-
old criteria in ChIP-chip and Chip-PET experiments influ-
enced the overall concordance between datasets, we
examined the data by generating 'recovery curves' (see Mate-
rials and methods; Figures 4 and 5). A binding event in one
experiment was considered 'recovered' by (or overlapping
with) a similar event in a second experimental type if both
events were within a fixed genomic distance (recovery dis-
tance) from each other. A typical p-value threshold of 0.001
was used initially to determine significant binding events in
ChIP-chip experiments, and a minimum number of 'overlap-
ping sequence reads' was used to establish bound regions in
ChIP-PET experiments (four or more overlapping reads for
OCT4 targets, and three or more overlapping reads for
NANOG). We generated two types of recovery curves to ana-
lyze the ChIP-chip and ChIP-PET data. The ChIP-PET recov-
ery curve examined the fraction of ChIP-PET regions
overlapping with the ChIP-chip data at a wide range of p-
value thresholds for the ChIP-chip experiments. In this
instance, the threshold criteria were kept constant for the
ChIP-PET experiments, and the ChIP-PET recovery (y-axis)
was plotted against a range of ChIP-chip p-values (x-axis).
Conversely, the other type of curve represented the ChIP-chip
recovery at varying ChIP-PET 'overlapping read' threshold
values. The ChIP-chip p-value threshold was kept constant at
0.001, and the ChIP-chip recovery (y-axis) was examined at
different numbers of ChIP-PET sequence reads (x-axis). We
examined each type of curve under a range of recovery
distances, as binding events identified by both methods may
not have exact overlaps due to differences in sample process-
ing and technologies.
Not surprisingly, we observed that the recoveries of OCT4
and NANOG targets obtained by one experimental method
Genomic distribution of (a) OCT4 and (b) NANOG binding sites on mouse chromosome 19, obtained by ChIP-chip analyses Figure 2
Genomic distribution of (a) OCT4 and (b) NANOG binding sites on mouse chromosome 19, obtained by ChIP-chip analyses.
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increased as the threshold value for the other method was
relaxed. The recoveries also increased as the distance permit-
ted between a ChIP-chip peak and corresponding ChIP-PET
peak was increased (Figures 4). As an example of these
results, converting the recoveries into percentages, among
OCT4-bound regions, 24% of the peaks identified by ChIP-
PET (>4 reads) were recovered in the ChIP-chip data (p-value
< 0.001) within a distance of 1 kb. Conversely, using the same
thresholds, 9.3% of the OCT4-bound peaks found by ChIP-
chip were recovered in the ChIP-PET data (Additional data
file 9). From the NANOG data we observed that 28.1% of the
ChIP-PET peaks (>3 reads) were recovered in ChIP-chip
bound regions (p-value < 0.001) within a 1 kb area. Con-
versely, the ChIP-chip percent recovery from ChIP-PET
bound regions (>3 reads) was 19.5% (Additional data file 10).
Therefore, these recovery curves illustrate the importance of
recovery distance and threshold calibration in examining
data from different sources.
Similar analyses were performed using the mouse chromo-
some 19 data and corresponding ChIP-PET regions. We noted
that the amount of overlap between ChIP-PET and ChIP-chip
increased with the more extensively tiled arrays (Figure 5).
This is because many targets identified in ChIP-PET experi-
ments would not be identified by the promoter arrays, since
regions outside of the promoter were not represented on
these arrays. In summary, the OCT4 and NANOG ChIP-chip
and ChIP-PET datasets show that the recovery among data-
sets varies as any of the threshold criteria for binding events
are altered. Further evaluation of the binding events identi-
fied through both techniques, by genetic manipulation of the
corresponding genes in ES cells, will lend better insight into
the genes responsible for maintaining pluripotency.
Previous reports have suggested that a lack of concordance
between array- and sequencing based technologies may also
be due to the repeat-masking feature of tiled microarrays as
well as a sequencing depth issue with ChIP-PET [11,14]. Since
99% of the ChIP-chip probes on our promoter arrays do not
have any major overlaps with repeat regions, and only 8.1% of
all ChIP-PET sequences fall in repeat-masked regions, we do
not expect the results of this study to change by any signifi-
cant degree if this small fraction of ChIP-PET sequences is
removed from the analysis. In order to further examine the
sequencing depth issue, the ChIP-chip and ChIP-PET data on
chromosome 19 were used to perform a sequence-depth anal-
ysis to examine the changes in ChIP-chip recovery as increas-
ing numbers of ChIP-PET sequences are randomly sampled
(Additional data files 3 and 14). According to our observations
for both OCT4 and NANOG, the number of ChIP-chip targets
recovered increased with the number of ChIP-PET reads sam-
pled, and did not approach a saturation point, even when all
ChIP-PET reads for chromosome 19 were sampled. This
result suggests that the lack of recovery of ChIP-chip targets
in the ChIP-PET data can, at least in part, be explained by a
lack of depth in sequencing.
Differentially regulated targets of OCT4 and NANOG
Since protein-DNA binding alone is not indicative of a regula-
tory event, the expression of OCT4 and NANOG binding
targets obtained through ChIP-chip and ChIP-PET was com-
pared by comparing binding data with previously published
OCT4 and NANOG RNA interference (RNAi) gene expression
profiles in ES cells [12]. The expression levels of targets deter-
mined exclusively by either technique, and those overlapping
in both, were examined in Oct4 or Nanog knockdown ES cells
(Table 1; Additional data files 11, 12 and 15) We found that
among the OCT4-bound targets (with corresponding Affyme-
GSE Spatial Visualizer snapshots showing illustrative examples of ChIP-chip and ChIP-PET data for (a) OCT4 and (b) NANOG Figure 3
GSE Spatial Visualizer snapshots showing illustrative examples of ChIP-chip and ChIP-PET data for (a) OCT4 and (b) NANOG. The fold enrichment for a 
single ChIP-chip replicate (for OCT4 or NANOG) is shown against the genomic coordinate scale for the gene (in base pairs). The grey boxes represent 
the locations of 'bound regions' from each of the factor's three ChIP-chip replicates. The white boxes show the overlapping ChIP-PET reads for the 
displayed region. A 'bound region' in ChIP-PET experiments had four or more overlapping reads in OCT4, and three or more overlapping reads in the 
case of NANOG. Gene exons and introns are represented by pink boxes and solid horizontal lines, respectively. For each visualized gene, the 
transcriptional start site, direction of transcription and RefSeq annotation derived from the UCSC database are also specified.
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trix probes) determined only by ChIP-chip, 33.9% were dif-
ferentially expressed upon Oct4 knockdown. Similarly, 29%
of the OCT4 targets detected solely by ChIP-PET were differ-
entially regulated. Interestingly, for OCT4 targets obtained by
both ChIP-PET and ChIP-chip, 70.3% showed changes in
gene expression upon downregulation of OCT4. In Nanog
knockdown ES cells, 21.4% of the targets determined solely by
ChIP-chip, and 14.8% identified only by ChIP-PET were dif-
ferentially expressed compared to normal ES cells. This per-
centage increased for targets that were identified by both
techniques, where 33.5% were differentially regulated upon
Nanog knockdown. These analyses also showed that among
the differentially regulated targets of NANOG, the distribu-
tion between up- and downregulated genes upon Nanog
knockdown was approximately equal. However, in the case of
OCT4 regulated targets, a larger percentage of genes was
downregulated (60.4%) upon Oct4 knockdown. These results
suggest that both NANOG and OCT4 can potentially activate
or repress their binding targets. Therefore, these analyses
OCT4 and NANOG promoter array recovery curves Figure 4
OCT4 and NANOG promoter array recovery curves. (a, c) The OCT4 (a) and NANOG (c) ChIP-PET recovery curves for the promoter arrays. These 
represent the fraction of ChIP-PET recovery under a range of ChIP-chip p-value cut-offs. (b, d) OCT4 (b) and NANOG (d) ChIP-chip recovery curves. 
These show the ChIP-chip percent recovery at varying ChIP-PET read thresholds. In all cases, recovery curves are made for a variety of distances (0-8 kb) 
permitted between a ChIP-chip peak and ChIP-PET read for them to be considered 'overlapping'.
Oct4 ChIP-PET Recovery (Promoter Array)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Oct4 ChIP-Chip Recovery (Promoter Array) 
0
0.2
0.4
0.6
0.8
1
1.2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
0 BP
100 BP
1000 BP
8000 BP
standard p-value threshold (0.001)
standard read threshold (>4)
C
h
I
P
-
P
E
T
 
R
e
c
o
v
e
r
y
ChIP-Chip Reco
v
er
y
ChIP-Chip p-values (Threshold Range) ChIP-PET reads (Threshold Range)
Nanog ChIP-PET Recovery (Promoter Array)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Nanog ChIP-Chip Recovery (Promoter Array)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 2 3 4 5 6 7 8 9 1 01 11 21 31 41 51 61 71 81 9
standard p-value threshold (0.001)
standard read threshold (>3)
C
h
I
P
-
P
E
T
 
R
e
c
o
v
e
r
y
ChIP-Chip Reco
v
er
y
ChIP-Chip p-values (Threshold Range) ChIP-PET reads (Threshold Range)
(a)
(d) (c)
(b)Genome Biology 2008, 9:R126
http://genomebiology.com/2008/9/8/R126 Genome Biology 2008,     Volume 9, Issue 8, Article R126       Mathur et al. R126.8
have revealed a higher-value set of OCT4- and NANOG-regu-
lated genes, by collectively examining the targets identified by
ChIP-chip and ChIP-PET.
The functional relevance of the ChIP-chip and ChIP-PET
data, as examined by GO analyses, had revealed that the
OCT4 and NANOG bound regions were significantly enriched
for transcriptional and developmentally important regulators
of gene expression. Similar observations had been made ear-
lier for these factors in human ES cells as well [10]. For
instance, among genes that displayed changes in expression
levels upon Oct4 RNAi-mediated knockdown, certain genes,
including Sox2 and Rif1, which have important roles in devel-
opment, were bound by OCT4 in both ChIP-chip and ChIP-
OCT4 and NANOG chromosome array recovery curves Figure 5
OCT4 and NANOG chromosome array recovery curves. (a, c) The OCT4 (a) and NANOG (c) ChIP-PET recovery curves for the chromosome array. 
These represent the fraction of ChIP-PET recovery under a range of ChIP-chip p-value cut-offs. (b, d) OCT4 (b) and NANOG (d) ChIP-chip recovery 
curves. These show the ChIP-chip percent recovery at varying ChIP-PET read thresholds. In all cases, recovery curves are made for a variety of distances 
(0-8 kb) permitted between a ChIP-chip peak and ChIP-PET read for them to be considered 'overlapping'.
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PET experiments. However, other genes that play a part in
cell-fate determination, such as Gdf3  and  Notch4  [18,19],
were bound by OCT4 only in the ChIP-chip experiments. A
separate set of differentially expressed OCT4 targets, includ-
ing Yap1 and Foxd3, which have been shown to have develop-
mentally important roles [20,21], were obtained only in the
ChIP-PET data. Similarly, observations were made in the
Nanog  RNAi knockdown data, which showed changes in
expression of target genes identified both exclusively and col-
lectively by the two technologies. Therefore, combining the
binding data obtained by both techniques, along with gene
expression data, has provided a more detailed overview of the
factors involved in the ES cell transcriptional circuitry. Fur-
ther genetic studies of these regions will lend deeper insight
into the mechanisms governing ES cell biology.
Discussion
ChIP-based technologies are being used extensively in identi-
fying protein-DNA interaction networks in a variety of cell
types and a number of varying conditions. In particular,
ChIP-PET and ChIP-chip have been used to identify the
mouse and human ES cell transcriptional circuitries, which
are largely regulated by the key pluripotency factors OCT4
and NANOG. Although each ChIP-based technology used in
the identification of these networks has its distinct advan-
tages, we find substantial differences in the data derived
through these different experimental methods. Recent tech-
nological comparisons have shown differences in the results
obtained by these methods, and illustrated the need to use
these data in a complementary manner [14]. We have used
ChIP-chip to uncover genomic regions bound by OCT4 and
NANOG in mouse ES cells, and expanded on previously pub-
lished ChIP-PET results, and find a large number of binding
sites identified exclusively by each technique. Therefore,
using these data in a complementary fashion provides a more
detailed overview of the OCT4 and NANOG transcriptional
networks.
We analyzed our ChIP-chip results for OCT4 and NANOG in
relation to existing ChIP-PET data. Since the criteria for
identification of genomic targets is different between plat-
forms, the datasets obtained by the two methods were exam-
ined against each other under an exhaustive range of
significance values. Recovery curves were used to measure
the recovery of targets obtained by keeping the binding
threshold for one technique constant and varying the thresh-
old values for the other method. As expected, for both OCT4
and NANOG targets, the ChIP-PET recovery decreased as the
ChIP-chip  p-value threshold was made more stringent. A
similar trend was observed for the ChIP-chip recovery when
the ChIP-PET read stringency was increased. Additionally, at
the same thresholds, this overlap decreased when the recov-
ery distance permitted between a ChIP-chip peak and ChIP-
PET peak was narrowed. Therefore, these recovery curves
revealed the necessity of recovery distance calibration in
examining binding experiments from multiple sources. Inter-
estingly, we also observed that the amount of recovery
between ChIP-chip and ChIP-PET data increased when the
whole chromosome arrays were used. Therefore, the criteria
used to determine a binding event, as well as the extent of
genome coverage, had an effect on the overlap between the
data obtained by the two methods. The recovery curves illu-
minated the sensitivity of recovery to distance threshold, and
provided a useful means to examine the datasets relative to
each other.
We combined the protein-DNA binding data with known
Oct4 and Nanog RNAi expression profiling data in order to
analyze the targets that are differentially regulated upon Oct4
or Nanog knockdown in ES cells. OCT4- and NANOG-bound
regions uncovered by both technologies, as well as the ones
obtained exclusively by each method, contained a number of
differentially regulated genes. Many of these genes encode
transcription factors and regulators of gene expression, which
are important in development. For instance, the expanded
OCT4 and NANOG regulatory network contained genes such
as Hoxa1, Foxd3, Msx2 and Hexb, which showed changes in
expression upon Oct4  or  Nanog  knockdown. These genes
have been shown to be important in cell fate specification,
and are involved in developmentally important signaling
pathways. Such additional targets identified by each tech-
n i q u e  c a n  b e  u s e d  t o  e x p a n d  t h e  E S  c e l l  t r a n s c r i p t i o n a l
regulatory framework, and thereby provide more detailed
Table 1
Differential expression of OCT4 and NANOG targets in RNAi experiments
Method for determining bound targets Percent of differentially expressed OCT4 targets on 
OCT4 knockdown
Percent of differentially expressed NANOG targets 
on NANOG knockdown
ChIP-chip only 33.9% (390/1,151) 21.4% (192/898)
ChIP-PET only 29% (114/393) 14.8% (91/616)
ChIP-chip + ChIP-PET 70.3% (83/118) 33.5% (73/218)
Percent of regulated genes
Upregulated 39.4% 50.6%
Downregulated 60.6% 49.4%Genome Biology 2008, 9:R126
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groundwork to understand pluripotency mechanisms.
Further genetic manipulations of each of these genes in ES
cells would be necessary to independently validate their con-
tributions to pluripotency.
Although both ChIP-chip and ChIP-PET technologies have
been useful in studying protein-DNA interactions on a
genome-wide scale, each method has its set of limitations. In
ChIP-chip, our observations are restricted to regions tiled on
the array platform, and the resolution is limited by the size of
the probes, their spatial distribution, as well as the average
fragment length of sonicated DNA hybridized to the arrays. In
ChIP-PET experiments, the bacterial cloning and sequencing
steps, as well as mapping issues, introduce scope for error.
We feel that a combination of more stringent mapping crite-
ria and the inherent noise in the sequencing procedure may
be responsible for the number of sequence reads that did not
match perfectly to the genome. Moreover, as indicated by our
sequence-depth analysis, the number of sequences obtained
from ChIP-PET experiments can be a limiting factor, since
more binding targets can be recovered through greater depth
in sequencing. Additionally, as in the case of ChIP-chip exper-
iments, the resolution of binding is limited by the average
DNA fragment size used in the ChIP experiment. We
observed some of these limitations in this study since there
was a significant number of OCT4 and NANOG targets that
had been identified by ChIP-PET, and did not have corre-
sponding probes tiled on the arrays used in the ChIP-chip
experiments. Apart from these limitations, it is also
important to consider that binding sites may be differentially
occupied at different times in the cell cycle since the chroma-
tin state changes at different times [22]. However, since it is
currently not feasible to culture ES cells in a synchronized
manner, such genome-wide analyses should be done with this
caveat in mind. In addition to this, another limitation to these
studies is that the processing of ES ce ll sa mples can vary
between different laboratories and also between different
batches of serum used to culture these cells. Finally, different
binding results may be obtained due to differences in ES cell
strains. Therefore, with the availability of binding informa-
tion from different cell strains [11], we can begin to address
such issues.
Apart from ChIP-chip and ChIP-PET, other ChIP based
methodologies, such as ChIP-SACO (serial analysis of chro-
matin occupancy) [23] and STAGE (sequence tag analysis of
genome enrichment) [24], have been used to determine pro-
tein-DNA interactions on a genome-wide scale. Most
recently, ChIP-Seq [25], a sequencing based technology, has
aimed to address many of the issues, such as genome cover-
age, sequencing depth and binding resolution, which are
encountered by other currently used techniques. With this
rapid change in technologies, it will be important to investi-
gate the results obtained from these techniques and incorpo-
rate them into our current understanding of regulatory
networks. Importantly, the use of multiple techniques has
been shown to produce variations in the information
obtained through individual platforms [14]. Using the data
obtained through these different methodologies in a comple-
mentary fashion provides a more thorough foundation for
further investigating these networks.
Conclusion
The results of this study provide a useful way to integrate pro-
tein-DNA interaction data that are obtained by different tech-
niques. We have used this to expand our current knowledge of
the mouse ES cell regulatory network that is orchestrated by
the transcription factors OCT4 and NANOG. Although both
the ChIP-chip and ChIP-PET technology platforms identified
different sets of binding events, a considerable number of
these events represented genes that were regulated by OCT4
and NANOG. Since a number of these genes have known roles
in important developmental pathways and in cell-fate specifi-
cation, it will be interesting to explore their biological roles
with respect to ES cell pluripotency. Therefore, this expanded
network provides a stronger foundation to further examine
biochemical and genetic interactions that regulate stem cell
properties. Moreover, the methods described to compare
datasets from different platforms would be very useful as data
from newer technologies, such as Chip-Seq, become availa-
ble. Since ES cells are a model system for studying develop-
mental processes, and are thought to hold great promise in
regenerative medicine, it will be important to gain a thorough
understanding of the means by which a stem cell maintains its
identity, and how it can be directed to form different cell
types. Our work will allow for a more detailed examination of
the components of this expanded stem cell circuitry and will
lend better insight into the mechanisms of pluripotency.
Materials and methods
ES cell culture
V6.5 murine ES cells (genotype 129SvJae × C57BL/6; male)
were grown at 5% CO2 at 37°C on gelatinized tissue-culture
plates. They were grown in DMEM (Gibco, 11965-118, Grand
Island, NY, USA) with 15% fetal bovine serum (FBS; Hyclone,
Lot No. ARC26080, South Logan, UT, USA), Leukemia inhib-
itory factor, 1% penicillin/streptomycin (100× stock from
Gibco, 15140-122), 1% L-glutamine (200 mM; Gibco, 25030-
081), 1% non-essential amino acids (100× stock from Gibco,
11140-050) [26]. Since the replication time of ES cells can
vary with different batches of serum, the doubling time of ES
cells grown with this batch of serum was calculated to be
approximately 16 hours. This doubling time was comparable
to that obtained with other lots of FBS (Hyclone, Lot numbers
ASJ30355 and ASB28896). Moreover, as an additional con-
trol, KH2 ES cells [27] were also cultured in these different
batches of FBS, and showed similar doubling times as v6.5 ES
cells The cells were grown without irradiated mouse
embryonic fibroblasts prior to the ChIP analyses in order to
minimize contamination from feeders.http://genomebiology.com/2008/9/8/R126 Genome Biology 2008,     Volume 9, Issue 8, Article R126       Mathur et al. R126.11
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Antibodies
F o r  C h I P  e x p e r i m e n t s ,  w e  u s e d  a n t i - N A N O G  ( B e t h y l ,  B L -
1162, Montgomery, TX, USA) and anti-OCT4 (SantaCruz, sc-
8628X, Santa Cruz, CA, USA), which have been previously
characterized for immunoprecipitation.
Chromatin immunoprecipitation
The ChIP protocol was similar to previously published studies
[10,28-30]. Briefly, for each location analysis reaction,
approximately 1.5 × 108 ES cells were grown at 70-80% con-
fluency. The cells were cross-linked by adding fresh 11% for-
maldehyde solution to the ES media for 10 minutes at room
temperature. The cells were washed twice with 1× phosphate-
buffered saline and scraped off the plates, pelleted and stored
at -80°C. They were then lysed and sonicated to solubilize
chromatin and shear the cross-linked DNA. Sonications were
performed with a Misonix Sonicator 3000 and sonicated at
power 7 for 12 × 30 second pulses (60 second pause between
pulses) at 4°C while the samples were immersed in a water
bath. The whole cell extract was incubated overnight on a
rotating platform at 4°C with 100 μl of Dyna1 Protein G mag-
netic beads, blocked with 0.05% bovine serum albumin/
phosphate-buffered saline and pre-incubated for 6 hours to
overnight with 10 μg of antibody of choice. The beads were
washed five times with radio immunoprecipitation assay
(RIPA) buffer and once with TE containing 50 mM NaCl.
Bound protein-DNA complexes were eluted off the beads in
elution buffer by occasional vortexing and heating at 65°C
overnight. Whole cell extract (saved from the sonication step)
was treated similarly for cross-link reversal. Following treat-
ment with RNaseA and Proteinase K, the immunoprecipi-
tated and whole cell extract DNA was purified by
phenol:chloroform:isoamyl alcohol extraction. The DNA was
blunted-end ligated to a universal linker and amplified using
a two-stage expansion PCR protocol (three reactions per sam-
ple were done for the second expansion and combined). The
amplified immunoprecipitated DNA and whole cell extract
DNA were labeled with Cy5 and Cy3 fluorophores, respec-
tively, using Invitrogen random primer labeling kits (Invitro-
gen, Carlsbad, CA, USA). DNA (1 μg) was used in a labeling
reaction and three labeling reactions were done per sample
and combined after purification. The labeled DNA was puri-
fied using Invitrogen BioPrime Array CGH module purifica-
tion kit. Five micrograms each of immunoprecipitated and
whole cell extract DNA was combined along with mouse Cot-
1 DNA and hybridized to each of the arrays in Agilent hybrid-
ization chambers for 40 hours at 65°C using the Agilent
hybridization protocol and reagents for 244 K arrays (Agilent,
Santa Clara, CA, USA). Arrays were then washed and scanned
as previously described. Three biological replicates were done
for each transcription factor in order to determine statistical
significance for binding targets.
Analysis of ChIP-chip data
Three biological replicates were examined for both OCT4 and
NANOG using mouse promoter arrays. The same samples
were also hybridized to mouse chromosome arrays. A probe
was marked 'bound' in a particular replicate if its Rosetta p-
value was below a pre-determined cutoff (usually 0.001,
although this was systematically varied for the recovery
curves). For each bound probe, a region around the probe was
marked 'bound' extending to the nearest unbound probe (or 1
kb, if the nearest probe was more than 1 kb away). A region
was marked as a 'peak' if it was bound in all three replicates.
The list of micro-RNAs to be analyzed was taken from version
8.0 of miRBase [33], which were mapped against NCBI build
34 of the mouse genome (mm6). We retained for analysis only
those micro-RNAs which had at least three probes from the
promoter array design mapped to within 4 kb of the miRBase
annotation. Of the original 267 miRBase annotations, 258
satisfied this requirement.
Mapping of ChIP-PET sequences to the mouse genome
Two sets of previously published ChIP-PET experiments for
OCT4 and NANOG were examined. These reads were mapped
to the Mouse mm6 genome sequence in order to be consistent
with the genome version used for the arrays in the ChIP-chip
experiments. The mapping was done using the BLAT
sequence alignment tool, with a step size of 5 and tile size of
11.
We received two FASTA files of sequences, each between 34
and 36 bp in length. Only those sequence hits reported by
BLAT that had at least 34 matched bases (corresponding to 0,
1, or 2 mismatches), and a gap-length of at least 10 bp, were
retained. Any sequences with more than one retained hit to
the mm6 genome were filtered out. The locations of the
unique hits for the sequences that remained were stored in a
database, and used for comparison with the ChIP-chip peaks.
Comparison of ChIP-chip to Chip-PET data
In order to examine if a bound region from ChIP-chip was
'matched' to another bound region from ChIP-PET, and vice
versa, a simple genomic distance threshold was determined.
If the two regions were on the same chromosome, and if the
edge of one region was within the recovery distance from the
edge of the other, then they were considered 'matched'. The
typical recovery distance used was 1 kb, although this was var-
ied systematically for the recovery curves. A recovery distance
of '0' represents only strictly overlapping regions that were
matched to each other.
Recovery curves
Recovery curves were produced for promoter and chromo-
some array data for OCT4 and NANOG. One curve was for the
ChIP-chip (p-value) cutoff, and the other for the ChIP-PET
(overlapping region) cutoff. In the ChIP-PET recovery curves,
fixed cutoffs of four overlapping reads for Oct4 and three
overlapping reads for Nanog were used to determine a 'back-
ground set' of ChIP-PET bound regions, as described above.
At that ChIP-PET cut-off, the number of ChIP-chip boundGenome Biology 2008, 9:R126
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regions was calculated for a range of p-value cut-offs. The per-
centage of background ChIP-PET bound regions that were
matched by at least one ChIP-chip bound region, at each p-
value threshold, was graphed. This was repeated for several
different matching distances.
For calculating the ChIP-chip recovery curve, this process was
repeated by holding the ChIP-chip binding threshold con-
stant. A background set of bound regions using ChIP-chip
was calculated using a p-value threshold of 0.001. The thresh-
old of overlapping reads used to call bound regions in ChIP-
PET was varied from 1 to an upper limit where no matched
regions were called. At each threshold, the fraction of the
background ChIP-chip bound regions matched by one of the
ChIP-Pet regions was calculated. This process was also
repeated for several different matching distances.
Sequence depth analysis
In order to carry out the sequence-depth analysis using data
from chromosome 19, the total number of ChIP-PET reads for
OCT4 and NANOG were calculated. For OCT4, 8,675 reads,
and for NANOG, 5,233 reads were mapped to chromosome
19. The number of ChIP-chip bound regions recovered for
both proteins was determined for differently sized subsets of
these ChIP-PET reads. We started with a random subset that
sampled 10% of the reads, and determined the ChIP-chip
recovery for that sample. This analysis was done for increas-
ingly large subsets of ChIP-PET reads in increments of 10%,
until all ChIP-PET reads on chromosome 19 were sampled.
For each subset size, the same number of reads was randomly
sampled ten times to calculate the average ChIP-chip recov-
ery and standard deviation in each case.
Expression analysis of OCT4 and NANOG targets
We wanted to determine the relevance to pluripotency for
OCT4 and NANOG binding targets obtained by ChIP-chip or
ChIP-PET. Previously published Oct and Nanog RNAi gene
expression profiles in ES cells were used for this analysis [12].
These experiments produced sets of Affymetrix probes, which
were differentially regulated in one or more of the replicates.
Those probes were matched to sets of gene names using an
Affymetrix-provided probe annotation file. A gene was deter-
mined as differentially regulated in either the Oct4 or the
Nanog knockdown experiments if it was associated with any
differentially regulated probe in the replicates of that factor's
experiments. A gene annotation was called 'bound by ChIP-
chip' if there was a ChIP-chip peak within ± 4 kb of the gene
annotation's start site. Equivalently, a gene annotation was
also bound by ChIP-PET if a ChIP-PET peak fell within the
same distance of the annotated start site (Additional data file
4). This allowed us to divide the set of differentially regulated
gene annotations into four categories: bound in both experi-
mental types, bound in neither, and bound in one (but not the
other).
Gene ontology analysis
A set of bound RefSeq gene identifiers was compiled for the
OCT4 and NANOG bound genes according to a standard cut-
off (p-value < 0.001 for ChIP-chip, and a maximum distance
of 4 kb from the gene start site for any annotated gene). The
sets of RefSeq identifiers were converted into sets of 'known
gene' gene symbols, using the kgXref table of the UCSC
Genome database [34]. A set of GO categories was down-
loaded from the Gene Ontology Project [31], and an updated
set of mouse annotations was downloaded from European
Bioinformatics Institute's (EBI) Gene Ontology Annotation
Project [32]. Since the GO categories are structured as a
directed graph, we propagated the annotations backwards
through the graph; a gene symbol was marked as annotated to
a GO category if the annotation was contained in the EBI
dataset, or if the GO category was the ancestor of a GO cate-
gory to which the gene symbol had already been assigned. A
background set of gene symbols was assembled from the cor-
responding 'known gene' symbols for any RefSeq gene identi-
fier that was tiled on the ChIP-chip array design. Given
foreground sets of genes defined by the ChIP binding experi-
ments, a background set of arrayed gene symbols, and a set of
EBI-derived GO category annotations for each symbol, we
calculated a list of GO categories ranked by their enrichment
in each of the four foreground gene sets. Enrichment was cal-
culated using the p-value of the hypergeometric probability
for the overlap of each test set with each GO category.
Abbreviations
ChIP, chromatin immunoprecipitation; EBI, European Bioin-
formatics Institute; ES, embryonic stem; FBS, fetal bovine
serum; GO, Gene Ontology; GSE, Genomic Spatial Events;
PET, paired-end ditag; RNAi, RNA interference.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a figure depict-
ing OCT4 ChIP-chip enrichment plots. Additional data file 2
is a figure depicting NANOG ChIP-chip enrichment plots.
Additional data file 3 is a figure showing sequence depth anal-
ysis for OCT4 and NANOG targets on chromosome 19. Addi-
t i o n a l  d a t a  f i l e  4  i s  a  f i g u r e  d e p i c t i n g  a n  e x a m p l e  o f
inconsistency in combining expression-profiling data with
binding information from ChIP-chip and ChIP-PET. Addi-
tional data file 5 is a table of protein coding gene promoter
regions that were bound by OCT4 and NANOG in ChIP-chiphttp://genomebiology.com/2008/9/8/R126 Genome Biology 2008,     Volume 9, Issue 8, Article R126       Mathur et al. R126.13
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and ChIP-PET experiments. Additional data file 6 is a table of
micro-RNA gene promoter regions that were bound by OCT4
and NANOG in ChIP-chip experiments. Additional data file 7
contains tables of GO analyses for OCT4 and NANOG bound
regions in ChIP-chip and ChIP-PET experiments. Additional
data file 8 contains tables of chromosome 19 regions that are
bound by OCT4 and NANOG in ChIP-chip experiments.
Additional data file 9 contains tables listing OCT4 ChIP-chip
and ChIP-PET recovery curve values for promoter and chro-
mosome array experiments. Additional data file 10 contains
tables listing NANOG ChIP-chip and ChIP-PET recovery
curve values for promoter and chromosome array experi-
ments. Additional data file 11 is a table of OCT4 bound genes
that are differentially expressed upon Oct4 knockdown. Addi-
tional data file 12 is a table of NANOG bound genes that are
differentially expressed upon Nanog knockdown. Additional
data file 13 contains tables listing gene-specific PCR binding
data for OCT4 and NANOG. Additional data file 14 contains
tables showing sequence depth analysis for OCT4 and
NANOG bound regions on chromosome 19. Additional data
file 15 contains supplementary information on additional
methods and materials and results. Additional data file 16 is a
summary of promoter array ChIP-chip binding data and cor-
responding ChIP-PET binding data for OCT4 and NANOG.
Additional data file 17 is a summary of chromosome array
ChIP-chip binding data and corresponding ChIP-PET bind-
ing data for OCT4 and NANOG.
Additional data file 1 OCT4 ChIP-chip enrichment plots Immunoprecipitate versus whole cell extract enrichment in three  biological replicate samples is shown for (a) the two-slide set pro- moter arrays and (b) chromosome 19 arrays. Click here for file Additional data file 2 NANOG ChIP-chip enrichment plots Immunoprecipitate versus whole cell extract enrichment in three  biological replicate samples is shown for (a) the two-slide set pro- moter arrays and (b) chromosome 19 arrays. Click here for file Additional data file 3 Sequence depth analysis for OCT4 and NANOG targets on chromo- some 19 Plots indicate the number of ChIP-chip targets recovered (y-axis)  when different percentages of ChIP-PET sequences are randomly  sampled. Error bars represent the standard deviation. Click here for file Additional data file 4 An example of inconsistency in combining expression-profiling  data with binding information from ChIP-chip and ChIP-PET The binding of NANOG at the REST gene promoter is identified by  both ChIP-chip and ChIP-PET. However, the binding event  detected in the ChIP-PET experiment is not within the region used  for combining the expression profiling information (± 4 kb around  the transcription start site). Consequently, the changed expression  of REST after NANOG knockdown is associated with NANOG bind- ing detected by ChIP-chip only and not ChIP-PET. Click here for file Additional data file 5 Protein coding gene promoter regions that were bound by OCT4  and NANOG in ChIP-chip and ChIP-PET experiments Protein coding gene promoter regions that were bound by OCT4  and NANOG in ChIP-chip and ChIP-PET experiments. Click here for file Additional data file 6 Micro-RNA gene promoter regions that were bound by OCT4 and  NANOG in ChIP-chip experiments Micro-RNA gene promoter regions that were bound by OCT4 and  NANOG in ChIP-chip experiments. Click here for file Additional data file 7 GO analyses for OCT4 and NANOG bound regions in ChIP-chip  and ChIP-PET experiments GO analyses for OCT4 and NANOG bound regions in ChIP-chip  and ChIP-PET experiments. Click here for file Additional data file 8 Chromosome 19 regions that are bound by OCT4 and NANOG in  ChIP-chip experiments Chromosome 19 regions that are bound by OCT4 and NANOG in  ChIP-chip experiments. Click here for file Additional data file 9 OCT4 ChIP-chip and ChIP-PET recovery curve values for promoter  and chromosome array experiments OCT4 ChIP-chip and ChIP-PET recovery curve values for promoter  and chromosome array experiments. Click here for file Additional data file 10 NANOG ChIP-chip and ChIP-PET recovery curve values for pro- moter and chromosome array experiments NANOG ChIP-chip and ChIP-PET recovery curve values for pro- moter and chromosome array experiments. Click here for file Additional data file 11 OCT4 bound genes that are differentially expressed upon Oct4  knockdown OCT4 bound genes that are differentially expressed upon Oct4  knockdown. Click here for file Additional data file 12 NANOG bound genes that are differentially expressed upon Nanog  knockdown NANOG bound genes that are differentially expressed upon Nanog  knockdown. Click here for file Additional data file 13 Gene-specific PCR binding data for OCT4 and NANOG Gene-specific PCR binding data for OCT4 and NANOG. Click here for file Additional data file 14 Sequence depth analysis for OCT4 and NANOG bound regions on  chromosome 19 Sequence depth analysis for OCT4 and NANOG bound regions on  chromosome 19. Click here for file Additional data file 15 Supplementary information on additional methods and materials  and results Supplementary information on additional methods and materials  and results. Click here for file Additional data file 16 Summary of promoter array ChIP-chip binding data and corre- sponding ChIP-PET binding data for OCT4 and NANOG Summary of promoter array ChIP-chip binding data and corre- sponding ChIP-PET binding data for OCT4 and NANOG. Click here for file Additional data file 17 Summary of chromosome array ChIP-chip binding data and corre- sponding ChIP-PET binding data for OCT4 and NANOG Summary of chromosome array ChIP-chip binding data and corre- sponding ChIP-PET binding data for OCT4 and NANOG. Click here for file
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